ACADIA Pharmaceuticals
ACAD
#3663
Rank
A$4.58 B
Marketcap
$27.56
Share price
0.40%
Change (1 day)
-36.37%
Change (1 year)

Earnings for ACADIA Pharmaceuticals (ACAD)

Earnings in 2024 (TTM): A$0.20 Billion

According to ACADIA Pharmaceuticals's latest financial reports the company's current earnings are A$0.92 Billion. In 2023 the company made an earning of -A$80.81 Million, an increase over its 2022 earnings that were of -A$0.34 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for ACADIA Pharmaceuticals from 2003 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) A$0.20 B-350.18%
2023 -A$80.81 Million-76.09%
2022 -A$0.34 Billion27.41%
2021 -A$0.27 Billion-40.38%
2020 -A$0.45 Billion19.88%
2019 -A$0.38 Billion-3.92%
2018 -A$0.39 Billion-15.04%
2017 -A$0.46 Billion6.33%
2016 -A$0.43 Billion64.55%
2015 -A$0.26 Billion77.47%
2014 -A$0.15 Billion143.69%
2013 -A$60.08 Million81.93%
2012 -A$33.03 Million-8.73%
2011 -A$36.18 Million-251.39%
2010 A$23.89 M-133.2%
2009 -A$71.99 Million-30.82%
2008 -A$0.11 Billion6.43%
2007 -A$97.78 Million25.89%
2006 -A$77.67 Million36.99%
2005 -A$56.69 Million37.22%
2004 -A$41.32 Million19.96%
2003 -A$34.44 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$59.34 Million-127.42%๐Ÿ‡บ๐Ÿ‡ธ USA
A$10.99 B 4,979.27%๐Ÿ‡บ๐Ÿ‡ธ USA
A$16.07 B 7,325.76%๐Ÿ‡บ๐Ÿ‡ธ USA
A$29.12 B 13,357.16%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$10.9 Billion-5,133.18%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$61.16 Million-128.26%๐Ÿ‡บ๐Ÿ‡ธ USA